Boston Scientific's subsidiary, Boston Scientific Japan KK, has reached an agreement with Fukuda Denshi to market and sell its cardiac rhythm management (CRM) devices and accessories throughout Japan.
Fukuda Denshi‘s sales resources, distribution network and service capabilities will complement Boston Scientific‘s existing sales and marketing organization and allow the company to reach substantially more accounts and expand the service it offers to its customers in Japan.
Fukuda Denshi will begin distributing Boston Scientific CRM products this quarter.
Boston Scientific Maulik Nanavaty president of Japan said they are pleased to reach agreement with Fukuda Denshi to distribute our CRM products in Japan.
"Our enhanced sales, distribution and service capabilities will help us better serve Japanese physicians and their patients while broadening our reach and growing our market share in this important market," Nanavaty said.